As part of our commitment to bring better solutions for people suffering from depression, Clexio is pleased to be collaborating with Genetika+. With the help of Genetika+’s unique personalized medicine platform, Clexio is working to develop new effective solutions for Major Depressive Disorder, to find the right therapeutic for each patient.
Please click HERE for more information on this collaboration.
Fusion innovation is how we align humanity, science, and technological innovation to improve patients’ lives.
Our unique approach allows us to identify the points of convergence between validated mechanisms of action and technology, to generate new patient-centric treatment possibilities.
We follow a structured process to come up with new ways to treat disease. It starts by listening to the patients. Then we cast our nets wide, gathering solutions from different fields and combining them in innovative and effective ways. Our diverse expertise allows us to converge medical needs and molecular science with our team’s technological ingenuity, until we find what works.
We listen closely to patients and physicians. We connect with their needs and their pain points.
Our team then imagines possibilities. We comb the vast world of molecular structures, mechanisms of action and use cases, using our cross-disciplinary perspective and technologies to home in on how different elements could fuse together to address patient needs.
The moment when the different pieces of the puzzle come together and an initial Product Concept emerges.
We start by testing the key hypothesis in the lab.
Once we have a confirmation from the Test stage, we rigorously assess the development pathway and streamline the project into Proof of Concept.
